Aug 02,2018

The State of Dermatologist-Pathologist Workflows

Currently, dermatologist-pathologist communication workflows are in dire need of an upgrade. Based on hand-written or manual documentation and communication systems, users are experiencing consequence of using outdated technologies within the dermatology industry. By adopting dermatology software such as DermEngine, medical professionals can remain connected with their pathology labs, clinics and hospitals. Equipped with the latest tools, users can digitize their documentation system to receive comprehensive lab request information.

PRODUCT

#ai/software

View Analyst & Ambassador Comments
Go to original news
Aug 28,2018

University Hospital of Zurich chooses Kaiku Health to improve the quality of care delivered to urological cancer patients

University Hospital of Zurich (USZ), one of the largest and most eminent teaching hospitals in Europe with approximately 1 500 physicians and scientists, selected Kaiku Health to automate patient-reported outcomes data collection from prostate and testicular cancer patients.

COLLABORATION PARTNERSHIP

#institution

#rpm

View Analyst & Ambassador Comments
Go to original news
Aug 13,2018

Working with Pharmacies to Provide Enhanced Skin Checks

Commonly recognized as a pillar within the healthcare community, pharmacies are a growing source of knowledge and assistance for patients in need of care (from flu shots to blood pressure tests). Most recently, visionary dermatologists are utilizing this trend to offer valuable skin check services via eTriage to patients.

PRODUCT

#platform

#ai/software

View Analyst & Ambassador Comments
Go to original news
Aug 15,2018

MetaOptima Attending World Congress Of Cancer Of The Skin

Once again the MetaOptima Team is excited to have the opportunity to attend the World Congress on Cancers of the Skin 2018 held in Sydney, Australia from August 15th-18th. Located at Booth #22, Maryam Sadeghi, Majid Razmara, Peter Birch and our distributors, Team Medical, will be showcasing the latest features of DermEngine (intelligent dermatology software) and MoleScope (digital dermoscope) to attendees.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 30,2018

Voluntis extends partnership with AstraZeneca in digital therapeutics for oncology

Voluntis (Euronext Paris: VTX), a digital biotech specialized in digital therapeutics, has announced the extension of its collaboration with AstraZeneca (NYSE: AZN) in the field of oncology. As part of the renewed agreement, the partners will implement a new phase of clinical evaluation of their digital therapeutic designed to support platinum resistant ovarian cancer patients treated with a combination of Cediranib plus Olaparib.

COLLABORATION PARTNERSHIP

#r&d

#dtx

View Analyst & Ambassador Comments
Go to original news
Jul 23,2018

What's New in Dermoscopy

In recent years, dermoscopy has gone through a countless number of changes. With dermatology tools like DermEngine’s Full-Body Imaging software, dermatologists can take images and map them to a 3D Body Map with the system identifying any changes between pictures over time for maximized efficiency of skin cancer detection.

PRODUCT

#connected device

#ai/software

#platform

View Analyst & Ambassador Comments
Go to original news
Jul 05,2018

MetaOptima Technology raises $8.6 million CAD

MetaOptima Technology is pleased to announce that it has raised $8.6 million CAD ($6.5 million USD) to expand its advanced dermatology and skin cancer imaging and management software, DermEngine™, into global markets. This marks a key advancement in the way skin cancer is screened, detected, and managed. Funds will be used to implement and build its intelligent dermatology platform DermEngine into the global dermatology industry beginning with Australia. MetaOptima Technology is pleased to announce that it has raised $8.6 million CAD ($6.5 million USD) to expand its advanced dermatology and skin cancer imaging and management software, DermEngine™, into global markets. This marks a key advancement in the way skin cancer is screened, detected, and managed.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jul 26,2018

Top 6 Reasons To Upgrade To A Mobile Dermoscope

Have you made the switch to a mobile dermatoscope? Although relatively new to the market, these little devices are making big waves in dermoscopy news for their portability, scalability, and accessibility. Read on to discover the six key distinctions that separate a mobile dermoscope from a traditional device and how this benefits dermatologists and their practices.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jul 06,2018

Research Finds Three Major Failings in some Apps Used for the Diagnosis of Skin Cancer

In the scramble to bring successful apps for the diagnosis of skin cancer to market there is a concern that a lack of testing is risking public safety, according to research led by the University of Birmingham. The research, outlined at the British Association of Dermatologists' Annual Meeting in Edinburgh, reviewed the medical literature on skin cancer apps to explore the number of apps on the market, ascertain how accurate they are, and what the benefits and limitations of these technological solutions are. Examples of apps include tele-dermatology (which involves sending an image directly to a dermatologist), photo storage (which can be used by individuals to compare photos monthly to look for changes in a mole), and risk calculation (based on colour and pattern recognition, or on fractal analysis).

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jul 16,2018

Results of the eCO trial published in the Journal of Clinical Oncology Informatics

Voluntis (the “Company” or “Voluntis” – ticker: VTX – ISIN Code: FR 0004183960), a company specialized in digital therapeutics, today announces that results for eCO, the digital therapeutic it developed for women with ovarian cancer in partnership with AstraZeneca and the National Cancer Institute, have been published in the Journal of Clinical Oncology (JCO®) Clinical Cancer Informatics.

CLINICAL STUDY

#dtx

#mobile app

View Analyst & Ambassador Comments
Go to original news